Visiongain publishes Global Neuromodulation Devices Market 2020-2030 report

Visiongain publishes Global Neuromodulation Devices Market 2020-2030 report

PR Newswire

LONDON, Aug. 26, 2020

LONDON, Aug. 26, 2020 /PRNewswire/ -- Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

Visiongain Logo

The neuromodulation devices market is estimated to grow at a CAGR of 12.1% over the forecast period.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 238-page report you will receive 130 charts– all unavailable elsewhere.

The 238-page Visiongain report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/global-neuromodulation-devices-report-2020-2030/#download_sampe_div

Report Scope

 

• Global Neuromodulation Devices market forecasts from 2020-2030

 

• This report also breaks down the revenue forecast for the global neuromodulation devices market by type:

• Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)

• Vagus Nerve Stimulation (VNS)

• Sacral Nerve Stimulation (SNS)

• Gastric Electrical Stimulation (GES)

• Other Applications

 

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

 

• This report provides individual revenue forecasts to 2030 for these regional and national markets:

North America: the US and Canada

Europe: France, Germany, Italy, U.K, Spain, Russia, Netherlands, Switzerland, Belgium, Austria, Rest of Europe

Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific

Latin America: Brazil, Mexico, Argentina, Rest of Latin America

• Rest of the World: Middle East, Africa

 

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

 

• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

 

• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry:

• Medtronic

• Boston Scientific

• Abbott Laboratories

• LivaNova PLC

• & Other Companies

 

To request a report overview of this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/global-neuromodulation-devices-report-2020-2030/

 

Did you know that we also offer a report add-on service? Email contactus@visiongain.com to discuss any customized research needs you may have.

 

Companies covered in the report include:

Abbott Laboratories

 

Advanced Uro-Solutions

 

Aleva Neurotherapeutics

 

Atrotech

 

Autonomic Technologies

 

Avery Biomedical

 

Axonics Modulation

 

BioControl Medical

 

Bioness, Inc.

 

BlueWind

 

Boston Scientific

 

CardioMEMS

 

CerebralRx

 

CerebroMed

 

Cogentix Medical

 

Covidien

 

CVRx, Inc

 

Deep Brain Innovations

 

Dymedix Corporation

 

ElectroCore INC

 

EndoNovo

 

EnteroMedics

 

Functional Neuromodulation

 

Genesys Capital

 

GlaxoSmithKline

 

Greatbatch

 

Halo Neuroscience

 

ImThera Medical

 

InCube Labs

 

InSightec

 

Integer Holdings Corporation

 

Jens Brøndum Frøkjær

 

Laborie Medical Technologies

 

Lake Region Medical

 

LivaNova

 

MagStim

 

MainStay Medical

 

Mayo Clinic

 

Medtronic

 

Medtronic Eindhoven Design Centre (MEDC)

 

Medtronic France SAS

 

MedtronicNeuro

 

MetaCure

 

Microtransponder

 

Mindray

 

MyndTec Inc.

 

Nanostim

 

NDI Medical

 

NeuImpulse

 

Neuromod Devices Ltd

 

NeuroPace

 

NeuroSigma

 

NeuroStar

 

Neurotherapies Reset

 

NeuroTherm

 

NeuroVista Corp

 

NeuSpera

 

Nevro

 

Newronika

 

Nexstim plc

 

Northwell Health

 

nUro Inc

 

Nuvectra Corporation

 

QiG Group,LLC

 

SceneRay

 

Scion NeuroStim

 

SetPoint Medical

 

SorinSpA

 

Soterix Medical

 

Spinal Modulation Inc

 

SPR Therapeutics

 

St. Jude Medical

 

Stimwave

 

Synapse Medical

 

The Neuroscience Center, LLC

 

Theranova, L.L.C.

 

TriHealth Inc.

 

Urolplasty

 

 

List of Companies Mentioned in the Report

 

Aalborg University Hospital

 

Australia Institute of Health and Welfare

 

China Food and Drug Administration (CFDA)

 

Dutch National Health Care Institute

 

Food and Drug Administtration (FDA)

 

Foundation Medical Partners

 

Gaceta Médica de México

 

Genesys Capital

 

Health Canada

 

Maastricht University Medical Center

 

National Institute for Health and Care Excellence (NICE)

 

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

 

Nordic Neuromodulation Society

 

North American Neuromodulation Society (NANS)

 

Northern California Institute of Research and Education

 

Organization for Economic Cooperation and Development (OECD)

 

Pharmaceuticals and Medical Devices Agency (PMDA)

 

University Hospital Regensburg

 

World Health Organization (WHO)

 

To see a report overview please e-mail contactus@visiongain.com

 

RELATED REPORTS:

Global Spinal Cord Stimulation Devices Market Forecast 2020-2030

Global Neurostimulation Devices Market 2019-2029

Global Precision Medicine Market Forecast 2019-2029

Global Ophthalmic Devices Market 2020-2030

The Global Respiratory Inhalers Market 2020-2030

Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

Voltar noticias em Inglês